Vitamin E inhibits experimental carcinogenesis and tumour angiogenesis

European Journal of Cancer Part B: Oral Oncology

Volumn 32, Issue 2, 1996, Pages 114-119

  Shklar, G ^a   Schwartz, J L ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

angiogenesis; carcinogenesis; TGF ; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHEROL SUCCINATE; DIMETHYLBENZ[A]ANTHRACENE; TRANSFORMING GROWTH FACTOR ALPHA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CHEEK MUCOSA; CONTROLLED STUDY; HAMSTER; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CANCER; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029988807     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(95)00077-1     Document Type: Article

References (39)

1. Shklar G. Inhibition of oral mucosal carcinogenesis by vitamin E. J Natl Cancer Inst 1982, 68, 791-797.
2. Suda D, Schwartz J, Shklar, G. Inhibition of experimental oral carcinogenesis by topical beta carotene. Carcinogenesis 1986, 7, 711-715.
3. Trickier D, Shklar G. Prevention by vitamin E of oral carcinogenesis. J Natl Cancer Inst 1987, 78, 165-169.
4. Shklar G, Schwartz J, Trickier DP, Niukian K. Regression by vitamin E of experimental oral cancer. J Natl Cancer Inst 1987,78, 987-992.
5. Schwartz J, Shklar G. Regression of experimental oral carcinomas by local injections of beta carotene and canthaxanthin. Nutr Cancer 1988, 11, 35-40.
6. Shklar G, Schwartz J, Grau D, Trickler DP, Wallace KD. Inhibition of hamster buccal pouch carcinogenesis by 13-cisretinoic acid. Oral Surg 1980, 50, 45-53.
7. Shklar G, Schwartz J. Oral cancer inhibition by micronutrients. The experimental basis for clinical trials. Oral Oncol 1993, 29B, 9-11.
8. Liehr JG, Roy D, Gladek A. Mechanism of inhibition of estrogeninduced renal carcinogenesis in male Syrian hamsters by vitamin C. Carcinogenesis 1989, 10, 1983-1988.
9. Schwartz J, Shklar G, Trickier DP. Vitamin C enhances the development of carcinomas in the hamster buccal pouch experimental model. Oral Surg 1993, 12, 718-722.
10. Meydani SN, Tengerdy RP. Vitamin E and immune response. In Packer L, Fuchs J, ed. Vitamin E in Health and Disease. New York, Marcel Dekker, 1993, 549.
11. Shklar G, Schwartz J. Tumor necrosis factor in experimental cancer: regression with alpha tocopherol, beta carotene, and algae extract. Eur J Cancer Clin Oncol 1988, 24, 839-850.
12. Shklar G, Schwartz J, Trickier DP, Reid S. Prevention of experimental cancer and immunostimulation by vitamin E (immunosurveillance). J Oral Path Med 1990, 19, 60-64.
13. Ehrlich P. Ueber den jetzigen Stand der Karcinom-Forschung. In Himmelweit F, ed. The Collected Papers of Paul Ehrlich. New York, Pergamon, 1957, Vol 2, 550.
14. Burnet F. The concept of immunological surveillance. Prog Exper Tumor Res 1970, 13, 1-20.
15. Schwartz J, Shklar G, Trickler DP. p53 in the anticancer mechanism of vitamin E. Oral Oncol 1993, 29B, 313-318.
16. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994, 54, 4855-4878.
17. Somers KD, Merrick MA, Lopez ME, Incognito MS, Schecter GL, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res 1992, 52, 5997-6000.
18. Shklar G, Schwartz JL. A common pathway for the destruction of cancer cells : experimental evidence and clinical implications. Int J Oncol 1994, 4, 215-224.
19. Shklar G, Schwartz J, Trickier DP, Reid S. Regression of experimental cancer by oral administration of combined alpha tocopherol and beta carotene. Nutr Cancer 1989, 12, 321-325.
20. Shklar G, Schwartz JL, Trickier DP, Reid-Cheverie S. The effectiveness of a mixture of beta carotene, alpha tocopherol, glutathione and ascorbic acid for cancer chemoprevention. Nutr Cancer 1993,20, 139-144.
21. Folkman J, Watson K, Ingber D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989, 339,58-61.
22. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Nail Cancer Inst 1989, 82, 4-6.
23. Weidner J. Tumor angiogenesis : review of current applications in tumor prognostication. Semin Diag Path 1993, 10, 302-303.
24. Liebovich SJ, Polverini PJ, Shepard HM, et al. Macrophageinduced angiogenesis is mediated by tumor necrosis factor alpha. Nature 1987, 329, 630-632.
25. Liotta L, Kleinerman J, Saidel G. Quantitative relationship of intravascular tumor cells, tumor vessels, and pulmonary metastasis following tumor implantation. Cancer Res 1974, 34, 997-1004.
26. Kim KJ, Li B, Winer J, Armanini A, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993, 362, 840-844.
27. Gasparini G, Weidner N, Bevilaqua P, et al. Tumor microvessel density, p53 expression, tumor size and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 1994, 12, 454-466.
28. Shklar G, Shklar DP, Schwartz JL. Vitamin E inhibits oral carcinogenesis and tumor angiogenesis (Abstr). J Dent Res 1995, 74, 88.
29. Shklar DP, Shklar G, Schwartz JL. Glutathione inhibits oral carcinogenesis and tumor angiogenesis (Abstr). J Dent Res 1995, 74, 88.
30. Gimenez-Conti IB, Slaga TJ. The hamster cheek pouch carcinogenesis model. J Cell Biochem 1993, 17F, 83-90.
31. Shklar G, Eisenberg E, Flynn E. Immuno-enhancing agents and experimental leukoplakia and carcinoma of the hamster buccal pouch. Prog Exper Tumor Res 1979, 24, 269-282.
32. Shklar G. Inhibition and regression of experimental oral cancer by beta carotene and vitamin E: emerging concepts. In Prasad KN, Santamaria L, Williams RM, eds. Nutrition in Cancer Prevention and Treatment. Totowa NJ, Humana Press, 1995.
33. Kiyoshi M, Rosai J, Burgdorf WHC. Localization of factor VIII-related antigens in vascular endothelial cells using an immunoperoxidase method. Am J Surg Pathol 1980, 4, 273-276.
34. Schreiber AB, Winkler ME, Dernynck R. Transforming growth factor oc, a more potent angiogenic mediator than epidermal growth factor. Science 1984, 226, 705-707.
35. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Path 1993, 143, 401-409.
36. Wong DTW, Gallagher GT, Gertz R, Change ALC, Shklar G. Transforming growth factor a in chemically transformed hamster oral keratinocytes. Cancer Res 1988, 48, 3130-3134.
37. Wong DTW. TGF and oral carcinogenesis. Oral Oncol 1993, 29B, 3-7.
38. Schwartz JL. EGF and related proteins during inhibition of oral cancer cell development (Abstr). J Dent Res 1995, 74, 1245.
39. Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin1. Science 1994,265, 1582-1584.